Reconstructive surgery is performed to repair or reconstruct tissue and/or organs that have been damaged by disease, injury, or other causes. Plastic surgery, on the other hand, is surgery performed to improve a patient’s appearance by changing the shape and size of the skin, muscles, and other tissues in the body. Plastic surgeries are one of the most popular and fastest-growing surgical procedures in the world today. The cosmetic surgery market is projected to be around $67 billion by 2026 exhibiting a CAGR of 3.6%.

Head & neck surgeries, breast surgeries and limb reconstruction surgeries are being performed on a daily basis by surgeons all over the world. Microsurgical procedures are used to successfully reconstruct defects resulting caused by trauma, birth defects, infection, or neoplasms. This includes a free flap procedure in which the flap is transferred to the recipient`s site. When designing a free flap, it is important to ensure that the flap is adequately perfused and there is no venous congestion. For this, it is necessary to evaluate the venous inflow and outflow.

Our device SpeccaFlow can measure the microcirculation in tissue area, particularly in the traumatised tissue and transplanted tissue, and it can be used in the detection of ischemia and necrosis of tissue area in the early stages and thus, can be used to monitor the healing progress. It helps to evaluate the severity of tissue damage in the wound and predict the survival rate of the tissue area. It is also used to assess the quality of tissue healing after surgery.

It helps surgeons objectively monitor and assess the vascularity of transplanted tissue by continuously monitoring the change in blood supply in the transplanted tissue. It can eliminate the clinical methods of vascularity assessment such as pin-pricking where flap tissue is being punctured by pricking with a pin to see if the blood supply is there or not for early detection and revision of vascular compromise in the first 48hrs after microvascular flap surgery.

Current methods based on the visual sign of an ischemic flap are subjective, unreliable, and very difficult to detect. It requires an experienced surgeon to monitor it effectively. There are high chances of misdiagnosis if done by a nurse or less experienced doctors.

Our AI software platform will increase sensitivity and specificity of vascularity measurement, based on the progressive data and it will predict the flap failure earlier for a timely salvage intervention. It will decrease the duration of the hospital stay of the patient by enabling the surgeons to take faster decisions during the surgical process and avoiding major complications and corrective surgeries.

It provides the freedom for surgeons to access and check for viability in neighbouring tissues as well for the impact of surgery without the need for an assistant. It will help the surgeons to place the flap at the most harvested/ or with a surplus blood flow which would give better results in terms of shorter healing time.